Monogenic diabetes clinic (MDC): 3-year experience
Authors:
Open Access
- 30 September 2022
- journal article
- research article
- Published by Springer Nature in Acta Diabetologica
- Vol. 60 (1) , 61-70
Abstract
Aim: In the pediatric diabetes clinic, patients with type 1 diabetes mellitus (T1D) account for more than 90% of cases, while monogenic forms represent about 6%. Many monogenic diabetes subtypes may respond to therapies other than insulin and have chronic diabetes complication prognosis that is different from T1D. With the aim of providing a better diagnostic pipeline and a tailored care for patients with monogenic diabetes, we set up a monogenic diabetes clinic (MDC). Methods: In the first 3 years of activity 97 patients with non-autoimmune forms of hyperglycemia were referred to MDC. Genetic testing was requested for 80 patients and 68 genetic reports were available for review. Results: In 58 subjects hyperglycemia was discovered beyond 1 year of age (Group 1) and in 10 before 1 year of age (Group 2). Genetic variants considered causative of hyperglycemia were identified in 25 and 6 patients of Group 1 and 2, respectively, with a pick up rate of 43.1% (25/58) for Group 1 and 60% (6/10) for Group 2 (global pick-up rate: 45.5%; 31/68). When we considered probands of Group 1 with a parental history of hyperglycemia, 58.3% (21/36) had a positive genetic test for GCK or HNF1A genes, while pick-up rate was 18.1% (4/22) in patients with mute family history for diabetes. Specific treatments for each condition were administered in most cases. Conclusion: We conclude that MDC maycontribute to provide a better diabetes care in the pediatric setting.Keywords
Funding Information
- Università degli Studi di Roma Tor Vergata
This publication has 27 references indexed in Scilit:
- Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort studyThe Lancet Diabetes & Endocrinology, 2018
- 17q12 Deletion Syndrome as a Rare Cause for Diabetes Mellitus Type MODY5The Journal of Clinical Endocrinology & Metabolism, 2018
- Monogenic diabetes in overweight and obese youth diagnosed with type 2 diabetes: the TODAY clinical trialGenetics in Medicine, 2018
- Monogenic Diabetes Accounts for 6.3% of Cases Referred to 15 Italian Pediatric Diabetes Centers During 2007 to 2012The Journal of Clinical Endocrinology & Metabolism, 2017
- Targeted next-generation sequencing reveals MODY in up to 6.5% of antibody-negative diabetes cases listed in the Norwegian Childhood Diabetes RegistryDiabetologia, 2016
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Six cases with severe insulin resistance (SIR) associated with mutations of insulin receptor: Is a Bartter-like syndrome a feature of congenital SIR?Acta Diabetologica, 2013
- Minimal incidence of neonatal/infancy onset diabetes in Italy is 1:90,000 live birthsActa Diabetologica, 2011
- Clinical Course of Genetic Diseases of the Insulin Receptor (Type A and Rabson-Mendenhall Syndromes)Medicine, 2004
- Insulin promoter factor-1 gene mutation linked to early-onset type 2 diabetes mellitus directs expression of a dominant negative isoprotein.Journal of Clinical Investigation, 1998